63 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Compensation Program Looking Forward: 2024 Compensation Program* Base Salary Annual Incentive (Paid in cash) Allows us to attract and retain talent … on sustainability and social impact Important component of attracting specialized talent Rewards creation of incremental shareholder value Provides a mix of short
DFAN14A
EX-99.1
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy materials by non-management
4:21pm
-positioned to reach those living with schizophrenia and Alzheimer’s disease psychosis. This announcement is a testament to the Karuna team’s talent, hard
8-K
EX-99.1
5hnya 7nvorrqt9
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.2
0of0smwyn124h48
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
v33 n3ydf3r5lvhlg
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.1
puult3jwb 63a
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
DEFA14A
wyqj4o ms
26 Apr 23
Additional proxy soliciting materials
4:38pm
8-K
EX-99.1
nys095uf0oqxun8awpn0
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
DEFA14A
ipbpu11ocxa9hq0bf
10 Apr 23
Additional proxy soliciting materials
5:12pm
DEFA14A
dwg ie9v7n
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
o0ras3
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-99.1
qxmcrlt1ql84z5
27 Oct 21
Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
9:46am
S-8 POS
csf2j d2b6lhi
4 May 21
Registration of securities for employees (post-effective amendment)
4:55pm
DEFA14A
4hj5m5wg193r
19 Apr 21
Additional proxy soliciting materials
7:41am